TaiMed Biologics Inc. (TPEX: 4147)
Taiwan flag Taiwan · Delayed Price · Currency is TWD
82.10
-0.40 (-0.48%)
Dec 20, 2024, 1:30 PM CST

TaiMed Biologics Balance Sheet

Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 2018 - 2014
Period Ending
Sep '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 2018 - 2014
Cash & Equivalents
1,021251.01274.11551.62572.09352.93
Upgrade
Short-Term Investments
1,152395.49309.93406.68629919
Upgrade
Trading Asset Securities
--58.75---
Upgrade
Cash & Short-Term Investments
2,173646.5642.79958.31,2011,272
Upgrade
Cash Growth
237.21%0.58%-32.92%-20.21%-5.57%-36.70%
Upgrade
Accounts Receivable
133.46160.4998.24157.78268.92210.09
Upgrade
Other Receivables
35.7328.1625.4935.4119.6920.81
Upgrade
Receivables
169.18188.65123.73193.19288.61230.9
Upgrade
Inventory
1,7001,2711,3891,1771,281876.04
Upgrade
Prepaid Expenses
4.3210.014.153.544.735.48
Upgrade
Other Current Assets
44.6435.635.082.592.9372.82
Upgrade
Total Current Assets
4,0912,1512,1652,3352,7782,457
Upgrade
Property, Plant & Equipment
871.25908.26957.741,0111,065940.32
Upgrade
Long-Term Investments
0.90.943.44232.63203249.36
Upgrade
Other Intangible Assets
563.37625.79724.38821.33940.16739.45
Upgrade
Other Long-Term Assets
207.96207.58210.57211.19210.59344.47
Upgrade
Total Assets
5,7343,8944,1014,6115,1964,731
Upgrade
Accounts Payable
564.8813.50.09122.586.16136.17
Upgrade
Accrued Expenses
12.737.4939.3951.64361.04227.18
Upgrade
Short-Term Debt
-200200---
Upgrade
Current Portion of Long-Term Debt
27.1126.9714.32---
Upgrade
Current Portion of Leases
2.262.182.021.951.931.85
Upgrade
Current Unearned Revenue
84.191.1257.4824.3437.5921.92
Upgrade
Other Current Liabilities
31.3219.9216.5724.5754.8140.99
Upgrade
Total Current Liabilities
722.39361.17329.86225.08461.52428.11
Upgrade
Long-Term Debt
474.88495.04521.68536536-
Upgrade
Long-Term Leases
25.6626.6728.1229.3831.3232.15
Upgrade
Long-Term Unearned Revenue
362.92444.04505.6877.9750.74683.25
Upgrade
Other Long-Term Liabilities
0.920.920.920.870.860.86
Upgrade
Total Liabilities
1,5871,3281,3861,6691,7801,144
Upgrade
Common Stock
2,7312,5302,5262,5232,5222,522
Upgrade
Additional Paid-In Capital
2,451986.67945.45925.144,8324,814
Upgrade
Retained Earnings
-1,016-934.56-740.22-470.93-3,921-3,737
Upgrade
Comprehensive Income & Other
-18.38-16.13-15.83-35.97-17.6-11.76
Upgrade
Shareholders' Equity
4,1472,5662,7152,9423,4163,586
Upgrade
Total Liabilities & Equity
5,7343,8944,1014,6115,1964,731
Upgrade
Total Debt
529.91750.86766.14567.32569.2534
Upgrade
Net Cash (Debt)
1,643-104.35-123.35390.98631.841,238
Upgrade
Net Cash Growth
----38.12%-48.96%-38.40%
Upgrade
Net Cash Per Share
6.24-0.41-0.491.552.514.91
Upgrade
Filing Date Shares Outstanding
273.08253.01252.55252.33252.22252.19
Upgrade
Total Common Shares Outstanding
273.08253.01252.55252.33252.22252.19
Upgrade
Working Capital
3,3681,7901,8352,1102,3162,029
Upgrade
Book Value Per Share
15.1910.1410.7511.6613.5414.22
Upgrade
Tangible Book Value
3,5841,9401,9912,1202,4762,847
Upgrade
Tangible Book Value Per Share
13.127.677.888.409.8211.29
Upgrade
Land
194.61194.61194.61194.61194.61194.61
Upgrade
Buildings
495.36493.95493.54493.12492.72359.17
Upgrade
Machinery
457.35455.56450.03446.9443.66272.62
Upgrade
Construction In Progress
-----137.56
Upgrade
Leasehold Improvements
4.644.644.644.644.644.64
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.